VEGFA and hematoma: Corticosteroids have been investigated as a potential adjunctive therapy for CSDH due to their anti-inflammatory effects, including the inhibition of vascular endothelial growth factor (VEGF) production, which plays a role in hematoma membrane formation and recurrence (13).